GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Syra Health Corp (NAS:SYRA) » Definitions » Asset Turnover

Syra Health (Syra Health) Asset Turnover : 0.37 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Syra Health Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Syra Health's Revenue for the three months ended in Mar. 2024 was $1.75 Mil. Syra Health's Total Assets for the quarter that ended in Mar. 2024 was $4.74 Mil. Therefore, Syra Health's Asset Turnover for the quarter that ended in Mar. 2024 was 0.37.

Asset Turnover is linked to ROE % through Du Pont Formula. Syra Health's annualized ROE % for the quarter that ended in Mar. 2024 was -155.13%. It is also linked to ROA % through Du Pont Formula. Syra Health's annualized ROA % for the quarter that ended in Mar. 2024 was -122.17%.


Syra Health Asset Turnover Historical Data

The historical data trend for Syra Health's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syra Health Asset Turnover Chart

Syra Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Asset Turnover
- 5.22 3.93 1.52

Syra Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.48 0.72 0.47 0.37

Competitive Comparison of Syra Health's Asset Turnover

For the Medical Care Facilities subindustry, Syra Health's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syra Health's Asset Turnover Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Syra Health's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Syra Health's Asset Turnover falls into.



Syra Health Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Syra Health's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=5.515/( (2.32+4.923)/ 2 )
=5.515/3.6215
=1.52

Syra Health's Asset Turnover for the quarter that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1.752/( (4.923+4.552)/ 2 )
=1.752/4.7375
=0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Syra Health  (NAS:SYRA) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Syra Health's annulized ROE % for the quarter that ended in Mar. 2024 is

ROE %**(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-5.788/3.731
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-5.788 / 7.008)*(7.008 / 4.7375)*(4.7375/ 3.731)
=Net Margin %*Asset Turnover*Equity Multiplier
=-82.59 %*1.4793*1.2698
=ROA %*Equity Multiplier
=-122.17 %*1.2698
=-155.13 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Syra Health's annulized ROA % for the quarter that ended in Mar. 2024 is

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=-5.788/4.7375
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-5.788 / 7.008)*(7.008 / 4.7375)
=Net Margin %*Asset Turnover
=-82.59 %*1.4793
=-122.17 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Syra Health Asset Turnover Related Terms

Thank you for viewing the detailed overview of Syra Health's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Syra Health (Syra Health) Business Description

Traded in Other Exchanges
N/A
Address
1119 Keystone Way North, No. 201, Carmel, IN, USA, 46032
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health. The Company has two main forms of revenue - healthcare staffing revenue and medical communication revenue. The majority of revenue is derived from healthcare staffing.
Executives
Sandeep Allam director, officer: President and Chair 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Feroz Syed 10 percent owner 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Deepika Vuppalanchi director, officer: Chief Executive Officer 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Vijayapal Reddy director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Avutu Reddy director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Ketan Paranjape director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Andrew Dahlem director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Sherron Rogers director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Joe D Thomas 10 percent owner 2046 EAST MURRAY-HOLIDAY ROAD, SALT LAKE CITY UT 84117
Sls Group Llc 10 percent owner 6582 S BIG COTTONWOOD CANYON RD. #200, SALT LAKE CITY UT 84121
Priya Prasad officer: CFO and COO 1119 KEYSTONE WAY N., #201, CARMEL IN 46032